Results: 1-8 |
Results: 8

Authors: Yokono, A Morita, S Someya, T Hirokane, G Okawa, M Shimoda, K
Citation: A. Yokono et al., The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients, J CL PSYCH, 21(6), 2001, pp. 549-555

Authors: Suzuki, Y Someya, T Shimoda, K Hirokane, G Morita, S Yokono, A Inoue, Y Takahashi, S
Citation: Y. Suzuki et al., Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol, THER DRUG M, 23(4), 2001, pp. 363-368

Authors: Shimoda, K Morita, S Hirokane, G Yokono, A Someya, T Takahashi, S
Citation: K. Shimoda et al., Metabolism of desipramine in Japanese psychiatric patients: The impact of CYP2D6 genotype on the hydroxylation of desipramine, PHARM TOX, 86(6), 2000, pp. 245-249

Authors: Someya, T Muratake, T Hirokane, G Shibasaki, M Shimoda, K Takahashi, S
Citation: T. Someya et al., Interindividual variation in bromperidol metabolism and relationship to therapeutic effects, J CL PSYCH, 20(2), 2000, pp. 175-180

Authors: Shimoda, K Morita, S Yokono, A Someya, T Hirokane, G Sunahara, N Takahashi, S
Citation: K. Shimoda et al., CYP2D610 alleles are not the determinant of the plasma haloperidol concentrations in Asian patients, THER DRUG M, 22(4), 2000, pp. 392-396

Authors: Someya, T Suzuki, Y Shimoda, K Hirokane, G Morita, S Yokono, A Inoue, Y Takahashi, S
Citation: T. Someya et al., The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: A preliminary study in a psychiatric population, PSY CLIN N, 53(5), 1999, pp. 593-597

Authors: Shimoda, K Someya, T Morita, S Hirokane, G Noguchi, G Yokono, A Shibasaki, M Takahashi, S
Citation: K. Shimoda et al., Lower plasma levels of haloperidol in smoking than in nonsmoking schizophrenic patients, THER DRUG M, 21(3), 1999, pp. 293-296

Authors: Hirokane, G Someya, T Takahashi, S Morita, S Shimoda, K
Citation: G. Hirokane et al., Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: The analysis of therapeutic drug monitoringdata, THER DRUG M, 21(1), 1999, pp. 82-86
Risultati: 1-8 |